Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.molmed.2014.03.002 http://scihub22266oqcxt.onion/10.1016/j.molmed.2014.03.002 C4082760!4082760!24703619     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Trends+Mol+Med 2014 ; 20 (7): 385-93 Nephropedia Template TP {{tp|p=24703619|t=2014. Extracellular vesicles: Emerging targets for cancer therapy |pdf=|usr=}}{{24703619}} gab.com Text Extracellular vesicles: Emerging targets for cancer therapy JO: Trends Mol Med http://www.kidney.de/pget.php?&tw=1&pmid=24703619 #FOAvip Extracellular vesicles (EVs), including exosomes, microvesicles and apoptotic bodies, are released by almost all cell types, including tumour cells. Through transfer of their molecular contents, EVs are capable of altering the function of recipient cells. Increasing evidence suggests a key role for EV-mediated intercellular communication in a variety of cellular processes involved in tumour development and progression, including immune suppression, angiogenesis and metastasis. Aspects of EV biogenesis or function are therefore increasingly being considered as targets for anti-cancer therapy. Here, we summarize the current knowledge on the contributions of EVs to cancer pathogenesis and discuss novel therapeutic strategies to target EVs to prevent tumour growth and spread. Twit Text FOAVip Extracellular vesicles: Emerging targets for cancer therapy ????Trends Mol Med http://www.kidney.de/pget.php?&tw=1&pmid=24703619 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=24703619 #FOAvip English Wikipedia <ref>{{Cite pmid|24703619}}</ref> Extracellular vesicles: Emerging targets for cancer therapy #MMPMID24703619 Vader P; Breakefield XO; Wood MJ Trends Mol Med 2014[Jul]; 20 (7): 385-93 PMID24703619show ga Extracellular vesicles (EVs), including exosomes, microvesicles and apoptotic bodies, are released by almost all cell types, including tumour cells. Through transfer of their molecular contents, EVs are capable of altering the function of recipient cells. Increasing evidence suggests a key role for EV-mediated intercellular communication in a variety of cellular processes involved in tumour development and progression, including immune suppression, angiogenesis and metastasis. Aspects of EV biogenesis or function are therefore increasingly being considered as targets for anti-cancer therapy. Here, we summarize the current knowledge on the contributions of EVs to cancer pathogenesis and discuss novel therapeutic strategies to target EVs to prevent tumour growth and spread. äExtracellular vesicles: Emerging targets for cancer therapy (epmc).pdf DeepDyve Pubget Overpricing